文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

减重手术对NAFLD患者肝脏体积与脂肪密度的动态影响

How bariatric surgery affects liver volume and fat density in NAFLD patients.
PubMed 文献 · Surg Endosc · 2017-12-07

这项两机构前瞻性研究纳入124例减重手术患者,49例完成全部五次MRI扫描。6个月时多余体重减少55.6±19.0%,BMI从45.3±5.9降至34.4±5.1 kg/m2,肝脏体积减少21.4±11.4%,PDFF从16.6±7.8%降至4.4±3.4%,83.7%患者脂肪变性消退;肝脏体积在术后1个月即达平台,而PDFF和BMI继续下降。LSG与LRYGB在肝脏体积和PDFF改善上无显著差异。

要点

  • 减重术后6个月83.7%的NAFLD患者肝脏脂肪变性消退(PDFF<6.4%)。
  • 肝脏体积在术后1个月即达平台,而PDFF和BMI继续下降。
  • LSG与LRYGB在改善肝脏体积和PDFF方面无显著差异。

核心结论

  • NAFLD患者接受减重手术后6个月肝脏体积和肝脂肪变性显著改善,83.7%患者脂肪变性消退。
  • 肝脏体积在术后1个月达到平台,但PDFF继续下降。
  • LSG与LRYGB在诱导肝脂肪变性消退方面疗效无差异。

研究设计与样本

  • IRB批准的两机构前瞻性研究,2010年10月至2015年6月招募124例减重手术患者。
  • 患者在基线及术前流质饮食后接受MRI,术中行肝活检,NAFLD阳性者在术后1、3、6个月复查MRI。
  • 49例(39.5%)完成全部五次扫描,从离线MRI图像计算肝脏体积和质子密度脂肪分数(PDFF)。

主要发现

  • 6个月时多余体重减少百分比(EWL%)为55.6±19.0%。
  • BMI从45.3±5.9降至34.4±5.1 kg/m2。
  • 平均肝脏体积从2464.6±619.4降至1874.3±387.8 cm3,体积变化21.4±11.4%。
  • PDFF从16.6±7.8%降至4.4±3.4%。
  • 6个月时83.7%患者脂肪变性消退(PDFF<6.4%)。

关键数值与推荐

  • 脂肪变性消退定义为PDFF<6.4%,基于既往发表的截断值。
  • LSG与LRYGB亚组间从基线至6个月肝脏体积或PDFF下降无统计学显著差异。

临床怎么用

  • 减重手术可有效改善NAFLD患者的肝脏体积和脂肪变性,术后6个月多数患者脂肪变性消退。
  • 术后1个月肝脏体积已明显下降,但脂肪含量持续改善至6个月,提示影像随访需关注不同指标的时间窗。
  • LSG和LRYGB在改善肝脏脂肪变性方面疗效相当,术式选择可综合考虑其他因素。

局限性

  • 仅49例(39.5%)患者完成全部五次MRI扫描,存在失访偏倚可能。
  • 研究未报告LSG与LRYGB亚组的具体样本量及统计学检验细节。
  • 随访时间仅至术后6个月,缺乏长期肝脏组织学结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is an epidemic in the obese population. Bariatric surgery is known to reverse multiple metabolic complications of obesity such as diabetes, dyslipidemia, and NAFLD, but the timing of liver changes has not been well described. MATERIALS AND METHODS: This was an IRB-approved, two-institutional prospective study. Bariatric patients received MRIs at baseline and after a pre-operative liquid diet. Liver biopsies were performed during surgery and if NAFLD positive, the patients received MRIs at 1, 3, and 6 months. Liver volumes and proton-density fat fraction (PDFF) were calculated from offline MRI images. Primary outcomes were changes in weight, body mass index (BMI), percent excess weight loss (EWL%), liver volume, and PDFF. Resolution of steatosis, as defined as PDFF < 6.4% based on previously published cutoffs, was assessed. Secondarily, outcomes were compared between patients who underwent laparoscopic sleeve gastrectomy (LSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB). RESULTS: From October 2010 to June 2015, 124 patients were recruited. 49 patients (39.5%) completed all five scans. EWL% at 6 months was 55.6 ± 19.0%. BMI decreased from 45.3 ± 5.9 to 34.4 ± 5.1 kg/m2 and mean liver volume decreased from 2464.6 ± 619.4 to 1874.3 ± 387.8 cm3 with a volume change of 21.4 ± 11.4%. PDFF decreased from 16.6 ± 7.8 to 4.4 ± 3.4%. At 6 months, 83.7% patients had resolution of steatosis. Liver volume plateaued at 1 month, but PDFF and BMI continued to decrease. There were no statistically significant differences in liver volume or PDFF reduction from baseline to 6 months between the LSG versus LRYGB subgroups. CONCLUSION: Patients with NAFLD undergoing bariatric surgery can expect significant decreases in liver volume and hepatic steatosis at 6 months, with 83.7% of patients achieving resolution of steatosis. Liver volume reduction plateaus 1-month post-bariatric surgery, but PDFF continues to decrease. LSG and LRYGB did not differ in efficacy for inducing regression of hepatosteatosis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Luo RB, Suzuki T, Hooker JC, et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc. 2017. PMID: 29218660. doi:10.1007/s00464-017-5846-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。